← Back to Search

Intubation Checklist for Rapid Sequence Intubation

Led By Josesph Roarty, MD
Research Sponsored by Community Medical Center, Toms River, NJ
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up at time of intubation
Awards & highlights


This trial is looking at how to improve the quality of care for patients who need rapid sequence intubation in the emergency department.

Who is the study for?
This trial is for any patient who needs an endotracheal intubation in the Emergency department. It's not open to individuals under 18 years old.Check my eligibility
What is being tested?
The study is testing whether using a checklist during rapid sequence intubation improves the quality and standardization of care compared to the usual procedures without a checklist.See study design
What are the potential side effects?
Since this trial focuses on process improvement rather than medication, it doesn't have typical drug side effects. However, risks may include those generally associated with endotracheal intubation.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of intubation
This trial's timeline: 3 weeks for screening, Varies for treatment, and at time of intubation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
First Pass Success Rate
Secondary outcome measures
Aspiration rate
Cardiac arrest
Cuff Leak
+8 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PostinterventionExperimental Treatment1 Intervention
Clinician intubation process after implementation and clinician education with a procedural checklist
Group II: PreinterventionActive Control1 Intervention
Normal clinician intubation process

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Rapid Sequence Intubation (RSI) involves the administration of sedatives and paralytics to facilitate quick and safe endotracheal intubation. Sedatives like etomidate or propofol induce rapid unconsciousness, while paralytics such as succinylcholine or rocuronium cause muscle relaxation, preventing reflexive movements and facilitating easier intubation. Hemodynamic management, including the use of agents like phenylephrine, ensures stable blood pressure during the procedure. Standardization and protocolization of these treatments are critical to minimize complications, ensure consistency, and improve overall patient outcomes during emergency intubations.
A Systematic Review on Surgical Treatments for Sulcus Vocalis and Vocal Fold Scar.Emergency intubation for acutely ill and injured patients.

Find a Location

Who is running the clinical trial?

Community Medical Center, Toms River, NJLead Sponsor
4 Previous Clinical Trials
455 Total Patients Enrolled
Josesph Roarty, MDPrincipal InvestigatorRobert Wood Johnson Barnabas Health Community Medical Center

Media Library

Rapid Sequence Intubation Clinical Trial Eligibility Overview. Trial Name: NCT05505799 — N/A
Rapid Sequence Intubation Research Study Groups: Postintervention, Preintervention
Rapid Sequence Intubation Clinical Trial 2023: Rapid Sequence Intubation Highlights & Side Effects. Trial Name: NCT05505799 — N/A
Rapid Sequence Intubation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05505799 — N/A
~233 spots leftby Jul 2025